Ionis Pharmaceuticals Inc (NASDAQ:IONS)

30.33
Delayed Data
As of Oct 21
 -0.19 / -0.62%
Today’s Change
29.01
Today|||52-Week Range
64.37
-46.36%
Year-to-Date
Intellia Moves Into Eye Treatments With SparingVision Deal
Oct 18 / GuruFocus News - Paid Partner Content
3 Stocks to Consider if the October Stock Market Sell-Off Worsens
Oct 17 / MotleyFool.com - Paid Partner Content
Biogen's (BIIB) Tofersen Reports Mixed Data From ALS Study
Oct 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close30.52
Today’s open30.42
Day’s range30.18 - 31.03
Volume721,557
Average volume (3 months)1,023,472
Market cap$5.0B
Data as of 3:59pm ET, 10/21/2021

Growth & Valuation

Earnings growth (last year)-252.66%
Earnings growth (this year)+42.17%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)-35.04%
P/E ratioNM
Price/Sales10.82
Price/Book5.84

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.07-0.22%
----
----
----
Data as of 3:59pm ET, 10/21/2021

Financials

Next reporting dateNovember 3, 2021
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$729.3M
Annual profit (last year)-$451.5M
Net profit margin-61.91%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Carlsbad, California

Forecasts